Established by the Estate of Khoo Teck Puat in 2025, this Fund supports research projects with significant potential to be translated into clinical applications such as effective medical therapies and/or drugs.
The inaugural project will focus on developing new tools for diagnosing cardiometabolic diseases and funding metabolomics research headed by Professor Wang Yibin, Director of Duke-NUS’ Cardiovascular & Metabolic Disorders programme. With limited therapeutic options currently available, the gift will be critical to the development of a state-of-the-art metabolism research centre in the School. It will also support Professor Wang and his team in acquiring top-notch technology and recruiting top-tier researchers to develop novel diagnostic tools and targeted treatments for cardiometabolic diseases.
More on Prof Wang and his work